See also this year's filing and all EDGAR filings for this company.
PDF Report 0001080709_2018_Arena_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 25, '100040 - Statement - Consolidated Statements of Operations and Comprehensive Loss2': 2}} |
Graph
Absolute values for 0001080709, Arena Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 281,280,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 30,131,000 |
| 3 | remainder_Assets | 27,864,000 |
| 4 | LiabilitiesCurrent | 72,327,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 30,228,817 |
| 9 | ResearchAndDevelopmentExpense | 70,864,457 |
| 10 | remainder_Expenses | 26,408,263 |
| 11 | remainder_Revenues | 82,605,662 |
| 12 | remainder_NetIncome | -1,293,620 |
| 13 | remainder_ComprehensiveNetIncome | 14,499,642 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 339,275,000 |
| 1 | Liabilities | 72,327,000 |
| 2 | Expenses | 127,501,537 |
| 3 | Revenues | 82,605,662 |
| 4 | StockholdersEquity | 266,948,000 |
| 5 | NetIncome | -46,189,495 |
| 6 | ComprehensiveNetIncome | -38,939,674 |
| 7 | BaseVar | 318,751,230 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.64 |
| 9 | EconomicCapitalRatio | 3.45 |
Edgar->Model Mapping
Feature Distribution
Change over Time
